DAGLA logo
DAGLA (Sn1-specific diacylglycerol lipase alpha)
FEATURES
Loading...
Loading...
FAMILY
DESCRIPTION
Also known as DGLA_HUMAN, DAGLA, C11orf11, KIAA0659, NSDDR. Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses.
Also known as DGLA_HUMAN, DAGLA, C11orf11, KIAA0659, NSDDR. Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses.
DAGLA logo

DAGLA

Sn1-specific diacylglycerol lipase alpha

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 1.95 1.67 1.44 1.20 0.35 126 1.57 1.36 1.29 1.21 -0.09 0.15
Bladder (BLCA) 406 1.85 1.22 1.01 0.79 -0.08 9 1.12 1.10 0.94 0.86 0.78 0.08
Breast (BRCA) 1067 1.91 1.40 1.28 1.12 0.13 178 1.85 1.48 1.39 1.31 1.00 -0.12
Cervical (CESC) 297 1.75 1.28 1.08 0.80 -0.02 10 1.41 1.31 1.24 1.13 0.68 -0.16
Cholangiocarcinoma (CHOL) 36 1.79 1.55 1.30 1.19 0.55 0
Colon (COAD) 443 2.29 1.77 1.66 1.52 0.55 166 1.90 1.70 1.58 1.37 -0.09 0.09
B-cell lymphoma (DLBC) 42 1.33 0.97 0.67 0.48 -0.16 337 1.37 0.85 0.66 0.44 -0.07 0.01
Esophageal (ESCA) 142 2.06 1.57 1.38 1.19 0.33 271 1.90 1.66 1.54 1.36 -0.09 -0.17
Glioblastoma (GBM) 160 2.05 1.73 1.63 1.55 0.84 214 2.25 1.89 1.77 1.65 -0.09 -0.15
Head and neck (HNSC) 432 1.61 1.14 0.94 0.69 -0.00 55 1.73 1.60 1.52 1.38 0.62 -0.58